Usa Financial Portformulas Corp Emergent Bio Solutions Inc. Transaction History

Usa Financial Portformulas Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$48.23 - $66.16 $428,523 - $587,831	-8,885 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $494,272 - $650,737	8,885 New	8,885 $585,000
Q3 2018 Oct 31, 2018	SELL	$52.05 - $66.51 $305,273 - $390,081	-5,865 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$48.33 - $55.64 $966 - $1,112	-20 Reduced 0.34%	5,865 $309,000
Q1 2018 Apr 03, 2018	BUY	$44.44 - $54.39 $261,529 - $320,085	5,885 New	5,885 $310,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

Stay updated on Usa Financial Portformulas Corp with notifications on news.